24992504|t|Genetic inhibition of phosphorylation of the translation initiation factor eIF2alpha does not block Abeta-dependent elevation of BACE1 and APP levels or reduce amyloid pathology in a mouse model of Alzheimer's disease.
24992504|a|beta-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1) initiates the production of beta-amyloid (Abeta), the major constituent of amyloid plaques in Alzheimer's disease (AD). BACE1 is elevated ~2-3 fold in AD brain and is concentrated in dystrophic neurites near plaques, suggesting BACE1 elevation is Abeta-dependent. Previously, we showed that phosphorylation of the translation initiation factor eIF2alpha de-represses translation of BACE1 mRNA following stress such as energy deprivation. We hypothesized that stress induced by Abeta might increase BACE1 levels by the same translational mechanism involving eIF2alpha phosphorylation. To test this hypothesis, we used three different genetic strategies to determine the effects of reducing eIF2alpha phosphorylation on Abeta-dependent BACE1 elevation in vitro and in vivo: 1) a two-vector adeno-associated virus (AAV) system to express constitutively active GADD34, the regulatory subunit of PP1c eIF2alpha phosphatase; 2) a non-phosphorylatable eIF2alpha S51A knockin mutation; 3) a BACE1-YFP transgene lacking the BACE1 mRNA 5' untranslated region (UTR) required for eIF2alpha translational regulation. The first two strategies were used in primary neurons and 5XFAD transgenic mice, while the third strategy was employed only in 5XFAD mice. Despite very effective reduction of eIF2alpha phosphorylation in both primary neurons and 5XFAD brains, or elimination of eIF2alpha-mediated regulation of BACE1-YFP mRNA translation in 5XFAD brains, Abeta-dependent BACE1 elevation was not decreased. Additionally, robust inhibition of eIF2alpha phosphorylation did not block Abeta-dependent APP elevation in primary neurons, nor did it reduce amyloid pathology in 5XFAD mice. We conclude that amyloid-associated BACE1 elevation is not caused by translational de-repression via eIF2alpha phosphorylation, but instead appears to involve a post-translational mechanism. These definitive genetic results exclude a role for eIF2alpha phosphorylation in Abeta-dependent BACE1 and APP elevation. We suggest a vicious pathogenic cycle wherein Abeta42 toxicity induces peri-plaque BACE1 and APP accumulation in dystrophic neurites leading to exacerbated Abeta production and plaque progression. 
24992504	75	84	eIF2alpha	Gene	229317
24992504	100	105	Abeta	Gene	11820
24992504	129	134	BACE1	Gene	23821
24992504	160	167	amyloid	Disease	MESH:C000718787
24992504	183	188	mouse	Species	10090
24992504	198	217	Alzheimer's disease	Disease	MESH:D000544
24992504	280	285	BACE1	Gene	23821
24992504	329	334	Abeta	Gene	11820
24992504	362	377	amyloid plaques	Disease	MESH:D058225
24992504	381	400	Alzheimer's disease	Disease	MESH:D000544
24992504	402	404	AD	Disease	MESH:D000544
24992504	407	412	BACE1	Gene	23821
24992504	438	440	AD	Disease	MESH:D000544
24992504	481	489	neurites	Disease	MESH:D058225
24992504	515	520	BACE1	Gene	23821
24992504	534	539	Abeta	Gene	11820
24992504	631	640	eIF2alpha	Gene	229317
24992504	669	674	BACE1	Gene	23821
24992504	764	769	Abeta	Gene	11820
24992504	785	790	BACE1	Gene	23821
24992504	844	853	eIF2alpha	Gene	229317
24992504	976	985	eIF2alpha	Gene	229317
24992504	1005	1010	Abeta	Gene	11820
24992504	1021	1026	BACE1	Gene	23821
24992504	1075	1081	adeno-	Species	
24992504	1092	1097	virus	Species	
24992504	1099	1102	AAV	Species	
24992504	1144	1150	GADD34	Gene	23645
24992504	1183	1204	eIF2alpha phosphatase	Gene	
24992504	1232	1241	eIF2alpha	Gene	229317
24992504	1242	1246	S51A	ProteinMutation	tmVar:p|SUB|S|51|A;HGVS:p.S51A;VariantGroup:0;OriginalGene:229317;CorrespondingGene:83939;CorrespondingSpecies:10090
24992504	1270	1275	BACE1	Gene	23821
24992504	1302	1307	BACE1	Gene	23821
24992504	1355	1364	eIF2alpha	Gene	229317
24992504	1449	1454	5XFAD	Disease	
24992504	1455	1470	transgenic mice	Species	10090
24992504	1518	1523	5XFAD	Disease	
24992504	1524	1528	mice	Species	10090
24992504	1566	1575	eIF2alpha	Gene	229317
24992504	1620	1625	5XFAD	Disease	
24992504	1652	1661	eIF2alpha	Gene	229317
24992504	1685	1690	BACE1	Gene	23821
24992504	1715	1720	5XFAD	Disease	
24992504	1729	1734	Abeta	Gene	11820
24992504	1745	1750	BACE1	Gene	23821
24992504	1815	1824	eIF2alpha	Gene	229317
24992504	1855	1860	Abeta	Gene	11820
24992504	1923	1930	amyloid	Disease	MESH:C000718787
24992504	1944	1949	5XFAD	Disease	
24992504	1950	1954	mice	Species	10090
24992504	1973	1980	amyloid	Disease	MESH:C000718787
24992504	1992	1997	BACE1	Gene	23821
24992504	2057	2066	eIF2alpha	Gene	229317
24992504	2199	2208	eIF2alpha	Gene	229317
24992504	2228	2233	Abeta	Gene	11820
24992504	2244	2249	BACE1	Gene	23821
24992504	2323	2331	toxicity	Disease	MESH:D064420
24992504	2352	2357	BACE1	Gene	23821
24992504	2393	2401	neurites	Disease	MESH:D058225
24992504	2425	2430	Abeta	Gene	11820
24992504	Association	MESH:D000544	11820
24992504	Association	MESH:D058225	23821
24992504	Positive_Correlation	11820	23821
24992504	Positive_Correlation	MESH:D000544	23821
24992504	Negative_Correlation	229317	23821

